Andrea M.D.'s Email Addresses & Phone Numbers

📖 Summary

Medical Doctor, European Board Certified in Rheumatology with more than 15 years of combined Clinical, Academic and BioPharmaceutical Industry experience. Umbrella core competences and track record of success covering Medical Affairs and Clinical Development in the Immunology Therapeutic area ranging from Mainstream to Ultra-Orphan Diseases (eg. Rheumatoid arthritis, Inflammatory Bowel Diseases, Gouty Arthritis, Systemic Juvenile Idiopathic Arthritis, Periodic Fevers). My mission is to deliver excellence in the clinical development of targeted therapies for Autoimmune/Autoinflammatory Diseases, engage peer-to-peer relationships and collaborations with the recognised Key Opinion Leaders' in the field, support the marketing strategies and the positioning messages in a consistent way with a good balance between science and business, but always aiming the best for the patients with severe diseases. My keywords are Mobility, Flexibility, Accountability, Competence, and above all "DO-IT-NOW". Previous positions in the Pharmaceutical Industry: Aug 1 2011- Aug 31 2014: Associate Global Program Medical Director Autoinflammatory Diseases- ILARIS (canakinumab)- Novartis - Basel Switzerland Sept 16 2008-Jul 29 2011: International Medical Leader - Rheumatology (ACTEMRA) - Hoffmann-La Roche - Basel Switzerland Aug 28th 2006 to Sept 10th 2008. Medical Director Inflammation (Gastroenterology, Rheumatology) – UCB Pharma SpA - Milan- Italy. Education: Oct 12th 1999: Graduate MD at University of Parma Medical School 2000-2003: Residency and Fellowship in Rheumatology at Department of Rheumatology -University of Ancona. Nov 18th 2003: Italian Board Certification in Rheumatology with Honors 2004-2006: Researcher at Università Politecnica delle Marche for the project: “Computerized management of clinical data in rheumatology”Global Head of Immunology Early Projects & Inflammatory Bowel Diseases @ From July 2015 to Present (6 months) Brussels Area, BelgiumInternational Medical Vice President Inflammation & GH @ From September 2014 to June 2015 (10 months) DenmarkAssociate Global Program Medical Director @ Leadership for the new Global Clinical Development program in Hereditary Periodic Fevers Leadership for the Global program in Difficult to Treat Gouty Arthritis Line management of one Clinical Science Director From April 2014 to August 2014 (5 months) Basel Area, SwitzerlandClinical Indication Leader - Ilaris (Canakinumab) - Autoinflammatory Diseases @ Responsible for the Global Clinical Development of the anti-IL1β monoclonal antibody ACZ885 (canakinumab) in Gouty arthritis and rare auto-immune/auto-inflammatory diseases Responsible for the design and implementation of pivotal phase III studies, submission and post-submission activities, interactions with health authorities worldwide (FDA, EMA, PMDA, Health Canada, Swiss Medic). Clinical member of the cross-indication Global Project Team involving functions from preclinical science/translational medicine to commercial and regulatory. From August 2012 to March 2014 (1 year 8 months) Basel Area, SwitzerlandPrincipal Medical Scientific Expert Autoimmunity (Canakinumab) @ Member of the Global Clinical Development of the anti-IL1β monoclonal antibody ACZ885 (canakinumab) in Gouty Arthritis. Responsible for the design and implementation of pivotal phase III studies, post-submission activities, interactions with health authorities worldwide (FDA, EMA, Health Canada, Swiss Medic). Clinical member of the cross-indication Global Project Team involving functions from preclinical science/translational medicine to commercial and regulatory. From August 2011 to August 2012 (1 year 1 month) Basel Area, SwitzerlandInternational Medical Leader - Rheumatology (Tocilizumab) @ Key Member of the Global Medical Affairs Team, in charge of providing Medical-scientific input on the development of the product positioning, marketing strategy, patients profiling. • Leadership of the International Medical Team, with the mandate to get input/endorsement for and alignement on the Global strategy by key Countries (top 5 EU, US and Canada) • Leadership for the development, review and approval of medical-marketing materials visual aids, digital marketing activities. • Leadership of the main medical-marketing activities during the launch phase (Satellite symposia at EULAR, publications, Global Launch events) From September 2008 to July 2011 (2 years 11 months) Basel Area, SwitzerlandMedical Director Inflammation (Certolizumab Pegol) @ - Responsible for the implementation of Phase III/IIIb Global studies in Italy, development and implementation of local phase IV studies and for the evaluation and approval of Investigator Initiated studies in Inflammatory Bowel Diseases and Rheumatoid Arthritis - Responsible for the development and implementation Medical Education initiatives and KOL management (symposia, publications, advisory board meetings) - Line management responsibilities for 4 Medical Science Liasons and 1 administrative assistant - Interim BU Manager responsibilities from July 2007 to September 2008 - Member of the Management Board of the Italian UCB Affiliate - Member of the EU and US launch readiness team for Cimzia From September 2007 to September 2008 (1 year 1 month) Milan Area, ItalyMedical Manager Inflammation (Certolizumab pegol) @ - Responsible for the implementation of Phase III/IIIb Global studies in Italy, development and implementation of local phase IV studies and for the evaluation and approval of Investigator Initiated studies in Inflammatory Bowel Diseases and Rheumatoid Arthritis - Responsible for the development and implementation Medical Education initiatives and KOL management (symposia, publications, advisory board meetings) - Member of the EU and US launch readiness team for Cimzia From August 2006 to September 2007 (1 year 2 months) Milan Area, ItalyConsultant Rheumatologist @ Direct care of patients with Rheumatic Conditions (chronic arthritides, connective tissue disorders, osteoarthritis, osteoporosis, crystal associated arthropaties, fibromyalgia). Researched, validated and implemented in routine care quantitative clinimetric methodologies (radiographic scoring methods, disease activity indices and patient reported outcomes) From November 2003 to July 2006 (2 years 9 months) Rheumatologist - Researcher @ - 2000-2003 Fellowship in Rheumatology - Author and co-author of several publications - Invited speaker on matter of “Outcome measures and Clinimetrics” on behalf of the Master in pharmacoeconomics at Center of Pharmacoeconomics – Dept. Pharmacologic Sciences – University of Milan. - Webmaster for the Supplements of Clinical Experimental Rheumatology edited by Prof. Ted Pincus "Contemporary Advances in Clinical Rheumatology" http://www.clinexprheumatol.org" - Founder of the first Rheumatology Podcast "Rheumatology Radio" (indexed on iTunes" - Member of the Working Party on Informatics (iReum) of Italian Society of Rheumatology and Coordinator of the Rheumatologic Electronic Health Record (MONITOR project) study group. - Coordinator and teacher of medical informatics on behalf of the CME courses organized by iReum - Student Member of American Medical Informatics Association (AMIA) From October 1999 to July 2006 (6 years 10 months) Rheumatology, Medicine, Magna cum Laude @ Università Politecnica delle Marche From 2000 to 2003 MD, Medicine & Surgery @ Università degli Studi di Parma From 1993 to 1999 Andrea M.D. is skilled in: Rheumatology, Immunology, Medical affairs, Clinical Development, Clinical Trials, Key Opinion Leader relationship, Strategic Thinking, Study Design, Pharmacoeconomics, Epidemiology, Biostatistics, Public Speaking, Outcomes Research, Pharmacoepidemiology, Clinical Research